Molecular cardiology: The Molecular Cardiology involves the study of the molecular mechanisms of cardiovascular biology and human cardiovascular diseases. It focuses on discovering novel pathways that modulate cardiac hypertrophy, aging and metabolic diseases with specific attention to interpreting bench findings to new bedside approaches and strategies.
Cellular cardiology: Heart failure is the chief cause of mortality worldwide. Cardiac remodeling is the adaptive mechanism that causes ventricular dysfunction. In present article the authors explain the elements of the human heart and their examination of basic functions and their inter-communication under both normal and pathological circumstances.
Title : Antiplatelet agents as a novel therapy of heart failure due to myocardial infarction
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada
Title : Advanced molecular and cellular mechanisms for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : System methods to define master regulator of cell identity in development and diseases
Kaifu Chen, Cardiology Department, Boston Children’s Hospital, Boston, MA, USA, United States
Title : Protecting cardiac potassium channels as a novel strategy to prevent ischemia-associated arrhythmias and sudden cardiac death
Shetuan Zhang, Queen’s University, Canada
Title : Advancements in atherothrombotic disease treatment: Unveiling the potential of SGLT2/1 Agents
Robert J Chilton, UT Health San Antonio, United States
Title : Assessment of the risk of cardiovascular complications in an unorganized adult population in the central region of Russia
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation